Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Capital Expenditures Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Capital Expenditures
-kr220m
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
-32%
Zealand Pharma A/S
CSE:ZEAL
Capital Expenditures
-kr29.7m
CAGR 3-Years
-27%
CAGR 5-Years
-59%
CAGR 10-Years
-19%
Ascendis Pharma A/S
NASDAQ:ASND
Capital Expenditures
-€1.5m
CAGR 3-Years
57%
CAGR 5-Years
22%
CAGR 10-Years
-1%
B
Bavarian Nordic A/S
CSE:BAVA
Capital Expenditures
-kr1.1B
CAGR 3-Years
-36%
CAGR 5-Years
-27%
CAGR 10-Years
-21%
F
Fluoguide AS
STO:FLUO
Capital Expenditures
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Capital Expenditures
-kr39k
CAGR 3-Years
71%
CAGR 5-Years
51%
CAGR 10-Years
26%

See Also

What is Genmab A/S's Capital Expenditures?
Capital Expenditures
-220m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Capital Expenditures amounts to -220m DKK.

What is Genmab A/S's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-32%

Over the last year, the Capital Expenditures growth was 45%. The average annual Capital Expenditures growth rates for Genmab A/S have been -1% over the past three years , 14% over the past five years , and -32% over the past ten years .

Back to Top